Drug search by name
Daclizumab Subcutaneous and Remifentanil Intravenous
Determining the interaction of Daclizumab Subcutaneous and Remifentanil Intravenous and the possibility of their joint administration.
Check result:
Daclizumab Subcutaneous <> Remifentanil Intravenous
Relevance: 11.12.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Daclizumab Subcutaneous
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Remifentanil Intravenous
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Daclizumab Subcutaneous-Reminyl
- Daclizumab Subcutaneous-Reminyl ER
- Daclizumab Subcutaneous-Remodulin
- Daclizumab Subcutaneous-Remodulin injection
- Daclizumab Subcutaneous-Remular-S
- Daclizumab Subcutaneous-Renacidin
- Remifentanil Intravenous-Dacogen
- Remifentanil Intravenous-Dacomitinib
- Remifentanil Intravenous-Dactinomycin
- Remifentanil Intravenous-Dactinomycin Injection
- Remifentanil Intravenous-Dactinomycin Intravenous
- Remifentanil Intravenous-Daklinza
Doktika World
Interaction with food and lifestyle
Disease interaction